Purchase Order HHSD2002017M93125P

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $238,709 firm fixed price call against its Blanket Purchase Agreement to Biosearch Technologies, Inc. (doing business as Biosearch Technologies) for EBOLA ASSAY KITS. The place of performance will be Petaluma, California. No set-aside designation was used for this contract, which must be completed by May 15, 2021. This award will deliver Ebola assay kits to the CDC, likely in support of...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $91,350 firm fixed price delivery order contract to Cepheid, a subsidiary of Danaher Corporation, for EBOLA ASSAY KITS. The contract will provide assay kits to test for the Ebola virus and supports the agency's chemical and biological defense programs. Performance will occur in Atlanta, Georgia over a three month period concluding in May 2022. No subcontractors or set aside designations were...

This federal contract award, W911QY21D0014|W911SR24F0082, was issued by the Joint PEO Chemical and Biological Defense (a Defense agency) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the delivery of Ebola tests and swabs to address future Ebola outbreaks in Africa, with a ceiling value of $91,350.00 and a completion date of May 30, 2025. The contract is a firm fixed-price delivery order and does not have a...

Biosearch Technologies, Inc. was awarded a $293,742 firm fixed price blanket purchase agreement call contract by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to deliver laboratory supplies for Ebola kits. As the prime contractor, Biosearch Technologies, Inc. division LGC Biosearch Technologies will provide the requested products and services under the contract. No set-aside designation was specified. The contract has a completion date of April...

This is a sole-source federal contract award to OraSure Technologies, Inc., a for-profit manufacturer of diagnostic medical testing products, to develop improvements to the OraQuick Ebola Rapid Antigen Test. The objective is to increase the test's sensitivity and shelf life, develop sustainable reagents to eliminate reliance on limited supplies, transition manufacturing to an automated line to improve quality and production speed, and purchase two lots of approximately 10,000 improved tests...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a subcomponent of the U.S. Department of Health and Human Services (HHS), to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the provision of a human anti-Zaire Ebola virus glycoprotein (GP) IgG ELISA kit and low NSB diluent bottle. The contract has a ceiling value of $82,765.00 and a performance period ending on May 1,...

This is a $10,495 firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the procurement of 20 units of the AMBIS # 1768645 Human Anti-Zaire-Ebola Virus Glycoprotein (GP) IgM ELISA Kit at a unit price of $516.00. The contract has a completion date of June 16, 2016 and was awarded on December 4, 2015. This contract does not have a...

This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the provision of a Human Anti-Zaire Ebola Virus Nucleoprotein (NP) IgG ELISA Kit, a quantitative 96-test kit. The contract has a ceiling value of $7,501.00 and a period of performance ending on May 22, 2016. The contract was awarded on April 22, 2016...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services (HHS), to Alpha Diagnostic International Inc. The award, valued at $13,666.00, is for the procurement of an "AMBIS #1709226 HUMAN ANTI-ZAIRE-EBOLA VIRUS GLYCOPROTEIN (GP) IGG ELISA KIT". This is a firm fixed-price purchase order with a completion date of November 14, 2014. The contract does not have a set-aside designation.

This federal contract award to Orasure Technologies Inc. (Orasure) is for the procurement of OraQuick Ebola Rapid Antigen Tests by the Centers for Disease Control and Prevention (CDC). The definitive contract, valued at $278,620.89, was awarded on August 1, 2016 with a completion date of November 30, 2016. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Orasure is a global manufacturer of oral fluid diagnostic products and...